Treatment of Mucosal Bolivian Leishmaniasis

Condition:   Mucosal Leishmaniasis Interventions:   Drug: Group 1: Miltefosine;   Drug: Group 2: Pentavalent Antimony;   Drug: Group 3: Liposomal amphotericin B Sponsors:   Fundacion Nacional de Dermatologia;   Hospital Dermatologico de Jorochito;   Centro Nacional de Enfermedades Tropicales CENETROP;   ABF Foundation for Medical Research Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials